Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with a high genetic risk of type 1 diabetes: the MIDIA study

Diabetologia

Volumn 57, Issue 10, 2014, Pages 2193-2200

  Cinek, Ondrej ^a   Stene, Lars C ^b   Kramna, Lenka ^a   Tapia, German ^b   Oikarinen, Sami ^c   Witsø, Elisabet ^b   Rasmussen, Trond ^b   Torjesen, Peter A ^d   Hyöty, Heikki ^c,e   Rønningen, Kjersti S ^d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e PIRKANMAA HOSPITAL DISTRICT   (Finland)

Author keywords

Autoimmunity; Enterovirus; Infancy; Longitudinal Study; RNA; RT PCR; Virus associated aetiology

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65; IA 2 PROTEIN; INSULIN; PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; HLA DQ ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; BLOOD CELL; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; ENTEROVIRUS; FEMALE; FINLAND; GENETIC RISK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NORWAY; PANCREAS ISLET; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; GENE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; NEWBORN; VIROLOGY;

AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS; FEMALE; GENES, MHC CLASS II; HLA-DQ ANTIGENS; HUMANS; INFANT, NEWBORN; MALE; RNA, VIRAL;

EID: 84935419990     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3327-4     Document Type: Article

References (24)

1. Stene LC, Rewers M (2012) Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies. Clin Exp Immunol 168:12–23
2. Hyoty H, Taylor KW (2002) The role of viruses in human diabetes. Diabetologia 45:1353–1361
3. Green J, Casabonne D, Newton R (2004) Coxsackie B virus serology and Type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med 21:507–514
4. Tauriainen S, Oikarinen S, Oikarinen M, Hyoty H (2011) Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol 33:45–55
5. Yeung WC, Rawlinson WD, Craig ME (2011) Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342:d35
6. Salminen KK, Vuorinen T, Oikarinen S et al (2004) Isolation of enterovirus strains from children with preclinical Type 1 diabetes. Diabet Med 21:156–164
7. Salminen K, Sadeharju K, Lonnrot M et al (2003) Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 69:91–98
8. Oikarinen S, Martiskainen M, Tauriainen S et al (2011) Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 60:276–279
9. Sadeharju K, Hamalainen AM, Knip M et al (2003) Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial. Clin Exp Immunol 132:271–277
10. Graves PM, Rotbart HA, Nix WA et al (2003) Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res Clin Pract 59:51–61
11. Tapia G, Cinek O, Rasmussen T et al (2011) Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 34:151–155
12. Stene LC, Witso E, Torjesen PA et al (2007) Islet autoantibody development during follow-up of high-risk children from the general Norwegian population from three months of age: design and early results from the MIDIA study. J Autoimmun 29:44–51
13. Honkanen H, Oikarinen S, Pakkanen O et al (2013) Human enterovirus 71 strains in the background population and in hospital patients in Finland. J Clin Virol 56:348–353
14. Beillard E, Pallisgaard N, van der Velden VH et al (2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 17:2474–2486
15. Walter SD, Elwood JM (1975) A test for seasonality of events with a variable population at risk. Br J Prev Soc Med 29:18–21
16. Hwang JY, Jun EJ, Seo I et al (2012) Characterization of infections of human leukocytes by non-polio enteroviruses. Intervirology 55:333–341
17. Yin H, Berg AK, Tuvemo T, Frisk G (2002) Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 51:1964–1971
18. Schulte BM, Bakkers J, Lanke KH et al (2010) Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. Viral Immunol 23:99–104
19. Perlman J, Gibson C, Pounds SB, Gu Z, Bankowski MJ, Hayden RT (2007) Quantitative real-time PCR detection of adenovirus in clinical blood specimens: a comparison of plasma, whole blood and peripheral blood mononuclear cells. J Clin Virol 40:295–300
20. Ruf S, Behnke-Hall K, Gruhn B et al (2012) Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation. J Clin Virol 53:186–194
21. Sadeharju K, Knip M, Hiltunen M, Akerblom HK, Hyoty H (2003) The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia 46:1100–1105
22. Oikarinen S, Tauriainen S, Hober D et al (2014) Virus antibody survey in different European populations indicates risk association between Coxsackievirus B1 and Type 1 diabetes. Diabetes 63:655–662
23. Viskari H, Ludvigsson J, Uibo R et al (2004) Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project. J Med Virol 72:610–617
24. Lonnrot M, Knip M, Marciulionyte D et al (1999) Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care 22:2086–2088